IL164088A0 - Human deubiquitinating protease gene on chromosome7 and its murineortholog - Google Patents

Human deubiquitinating protease gene on chromosome7 and its murineortholog

Info

Publication number
IL164088A0
IL164088A0 IL16408803A IL16408803A IL164088A0 IL 164088 A0 IL164088 A0 IL 164088A0 IL 16408803 A IL16408803 A IL 16408803A IL 16408803 A IL16408803 A IL 16408803A IL 164088 A0 IL164088 A0 IL 164088A0
Authority
IL
Israel
Prior art keywords
murineortholog
protease gene
deubiquitinating protease
human deubiquitinating
human
Prior art date
Application number
IL16408803A
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0218518.9A external-priority patent/GB0218518D0/en
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL164088A0 publication Critical patent/IL164088A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16408803A 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome7 and its murineortholog IL164088A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36660102P 2002-03-22 2002-03-22
GBGB0218518.9A GB0218518D0 (en) 2002-03-22 2002-08-09 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
PCT/US2003/008590 WO2003083050A2 (en) 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog

Publications (1)

Publication Number Publication Date
IL164088A0 true IL164088A0 (en) 2005-12-18

Family

ID=28676509

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16408803A IL164088A0 (en) 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome7 and its murineortholog

Country Status (8)

Country Link
EP (1) EP1495117A4 (en)
JP (1) JP2005520567A (en)
AU (1) AU2003230701C1 (en)
BR (1) BR0307759A (en)
CA (1) CA2479647A1 (en)
IL (1) IL164088A0 (en)
MX (1) MXPA04006975A (en)
WO (1) WO2003083050A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006247A2 (en) * 1995-08-09 1997-02-20 Dana Farber Cancer Institute Deubiquitinating enzymes that regulate cell growth
JP2003510024A (en) * 1999-08-09 2003-03-18 インサイト・ゲノミックス・インコーポレイテッド Proteases and protease inhibitors
AU1071901A (en) * 1999-09-29 2001-04-30 Millennium Pharmaceuticals, Inc. 23431, a novel human ubiquitin protease

Also Published As

Publication number Publication date
WO2003083050A3 (en) 2004-02-26
BR0307759A (en) 2004-12-21
AU2003230701A1 (en) 2003-10-13
EP1495117A4 (en) 2005-06-08
AU2003230701B2 (en) 2008-06-05
MXPA04006975A (en) 2004-11-10
EP1495117A2 (en) 2005-01-12
JP2005520567A (en) 2005-07-14
CA2479647A1 (en) 2003-10-09
AU2003230701C1 (en) 2009-08-27
WO2003083050A2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
EP1539941A4 (en) Adzymes and uses thereof
EG25097A (en) Piprazinyl and diazapanyl benzamides and benzthioamides.
IL166377A0 (en) Vrgfr-2 and vgefr-3 inhibitory and anthranylamidpyrimidines
EP1466982A4 (en) Pyroglutamyl peptidase and its gene
EP1652855A4 (en) Polypeptides having brain -localizing activity and uses thereof
PL375355A1 (en) Novel lipases and uses thereof
AU2003215052A8 (en) Proteolytic fermenter
GB2408530B (en) Well completion systems and methods
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003231827A8 (en) Pseudo-tissues and uses thereof
TWI348914B (en) Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
EP1496122A4 (en) Novel meloidogyne-resistance gene and utilization thereof
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003262744A8 (en) Alpha-amylase assay and uses thereof
EP1644476A4 (en) Novel phytase and gene
IL164088A0 (en) Human deubiquitinating protease gene on chromosome7 and its murineortholog
AU2003300859A8 (en) Carrier-ligand fusions and uses thereof
EP1589101A4 (en) Novel protein and its gene
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
EP1541677A4 (en) Novel proteins and use thereof
EP1577322A4 (en) Novel proteins and use thereof
AU2003216442A8 (en) Enkurin and uses thereof
EP1699809A4 (en) Amniotic-derived peptide and uses thereof
GB0207624D0 (en) Chemokine and uses thereof
GB0209024D0 (en) Gene and protein